Be the first to review this item
Mebicar (Tetramethyltetraazabicyclooctandionum) - the drug belongs to the anxiolytic, stress-protective, neuroprotective agents. It improves the oxygen supply of the myocardium tissue; normalizes impaired electrolyte balance of the blood, the content of potassium ions in the plasma, red blood cells and the cells of the myocardium; enhances protein synthesis and increased cell energy resources.
Adjusts disturbed night's sleep without having a direct hypnotic action. It has no anticholinergic effect and miorelaksantnm, does not violate the coordination of movements. Facilitates or relieves nicotine withdrawal symptoms.
The drug belongs to the group of day tranquilizers and has no direct hypnotic action, however, in the treatment potentiates the effect of other hypnotic drugs. With long-term use of the drug noted improvement in nocturnal sleep, normalization of sleep patterns, facilitating sleep, reduce the frequency of nightmares.
In addition, the drug has a strong nootropic effect, promotes the normalization of the state with stress and mental stress. Mebicar improves memory and the ability to articulate thoughts, optimizes the process of thinking, has a marked effect in paralogs, moralizing, incoherence and acceleration of speech.
Mebicar helps to reduce nicotine and alcohol withdrawal.
Has an antioxidant effect, protects cells from free radicals and peroxide compounds. It has normastenicheskimi properties. The drug helps normalize lipid metabolism by altering the ratio of low-density lipoprotein and high-density lipoprotein, reduces the level of cholesterol in the blood.
Mebicar in the treatment of patients suffering from coronary heart disease improves trophism infarction, due to an increase in coronary blood flow. Under the influence of the drug increases the strength of cardiac contractions, normal vascular permeability, reduces blood viscosity, reduced intravascular erythrocyte aggregation.
The drug does not cause euphoria, it has not developed addiction and dependence.
Drug after oral administration is well absorbed in the gastrointestinal tract. Due to the chemical inertness of the drug does not affect food intake at mebicar extent of absorption of the drug. The drug is developed for 20-30 minutes and lasts up to 6 hours. The drug is not metabolized and accumulates in the body. The half-life is about 18 hours. Write mainly in the urine in unchanged form is output to 90% of the dose on the first day.
Return with urine completely during the day
Inside, regardless of meals.
According to 0.3-0.9 g 2-3 times a day.
The maximum single dose - 3 g daily - the exchange rate of 10 for the prevention and treatment - from a few days to 2-3 months, depending on the situation, for mental disorders - up to 6 months.
Allergic reactions (itching) at high doses - a short-term slight decrease in blood pressure, hyperthermia (increase in body temperature to 1-1.5 ° C), dyspepsia. Lowering blood pressure and body temperature is not an indication for discontinuation of the drug and are normalized independently.
It enhances the effect of sleeping pills and drugs.
Important notice- the outer box design may vary before prior notice!
Someone from the Denmark - just purchased the goods:
Taflotan eye drops 0.0015% 0.3ml 30 pieces